2026-06-300001648257--12-312026Q2false00016482572026-01-012026-06-300001648257us-gaap:CommonStockMember2026-01-012026-06-300001648257us-gaap:CommonStockMember2025-01-012025-06-300001648257us-gaap:RetainedEarningsMember2026-06-300001648257us-gaap:ParentMember2026-06-300001648257us-gaap:NoncontrollingInterestMember2026-06-300001648257us-gaap:AdditionalPaidInCapitalMember2026-06-300001648257us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-06-300001648257us-gaap:RetainedEarningsMember2025-12-310001648257us-gaap:ParentMember2025-12-310001648257us-gaap:NoncontrollingInterestMember2025-12-310001648257us-gaap:AdditionalPaidInCapitalMember2025-12-310001648257us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-12-310001648257us-gaap:RetainedEarningsMember2025-06-300001648257us-gaap:ParentMember2025-06-300001648257us-gaap:NoncontrollingInterestMember2025-06-300001648257us-gaap:AdditionalPaidInCapitalMember2025-06-300001648257us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-06-300001648257us-gaap:RetainedEarningsMember2024-12-310001648257us-gaap:ParentMember2024-12-310001648257us-gaap:NoncontrollingInterestMember2024-12-310001648257us-gaap:AdditionalPaidInCapitalMember2024-12-310001648257us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310001648257hcm:HCMLShareOptionSchemeMember2024-01-012024-12-310001648257hcm:HCMLShareOptionSchemeMember2024-12-310001648257hcm:HCMLShareOptionSchemeMember2025-01-012025-12-310001648257hcm:HCMLShareOptionSchemeMember2025-12-310001648257srt:MaximumMemberhcm:HCMLShareOptionSchemeMember2026-01-012026-06-300001648257hcm:HCMLShareOptionSchemeMember2015-04-242015-04-240001648257hcm:LongTermIncentivePlanMember2025-01-012025-12-310001648257hcm:LongTermIncentivePlanMember2024-12-310001648257hcm:AwardsVestingInFourYearsMemberhcm:HCMLShareOptionSchemeMember2026-01-012026-06-300001648257hcm:ExecutiveDirectorMemberhcm:HCMLShareOptionSchemeMember2025-06-012025-06-300001648257us-gaap:OtherNoncurrentLiabilitiesMember2026-06-300001648257hcm:OtherPayablesAccrualsAndAdvanceReceiptsMember2026-06-300001648257us-gaap:OtherNoncurrentLiabilitiesMember2025-12-310001648257hcm:OtherPayablesAccrualsAndAdvanceReceiptsMember2025-12-310001648257us-gaap:RelatedPartyMemberhcm:OtherVenturesSegmentMember2026-01-012026-06-300001648257us-gaap:NonrelatedPartyMemberhcm:OtherVenturesSegmentMember2026-01-012026-06-300001648257us-gaap:NonrelatedPartyMemberhcm:OncologyOrImmunologySegmentMember2026-01-012026-06-300001648257hcm:RelatedPartyTransactionSalesOfGoodsMemberus-gaap:EquityMethodInvesteeMember2026-01-012026-06-300001648257hcm:OtherCollaborationRoyaltiesRevenueMemberus-gaap:NonrelatedPartyMember2026-01-012026-06-300001648257hcm:OtherCollaborationRoyaltiesRevenueMemberhcm:OncologyOrImmunologySegmentMember2026-01-012026-06-300001648257hcm:OtherCollaborationLicensingRevenueMemberus-gaap:NonrelatedPartyMember2026-01-012026-06-300001648257hcm:OtherCollaborationLicensingRevenueMemberhcm:OncologyOrImmunologySegmentMember2026-01-012026-06-300001648257hcm:MarketedProductsMemberhcm:OncologyOrImmunologySegmentMember2026-01-012026-06-300001648257hcm:LicenseAndCollaborationsManufacturingSupplyMemberhcm:OncologyOrImmunologySegmentMember2026-01-012026-06-300001648257hcm:GoodsDistributionMemberhcm:OtherVenturesSegmentMember2026-01-012026-06-300001648257hcm:CommercializationServicesMemberhcm:OncologyOrImmunologySegmentMember2026-01-012026-06-300001648257hcm:CollaborationResearchAndDevelopmentMemberus-gaap:NonrelatedPartyMember2026-01-012026-06-300001648257hcm:CollaborationResearchAndDevelopmentMemberhcm:OncologyOrImmunologySegmentMember2026-01-012026-06-300001648257us-gaap:RelatedPartyMember2026-01-012026-06-300001648257us-gaap:NonrelatedPartyMember2026-01-012026-06-300001648257hcm:UnitedStatesAndOthersMember2026-01-012026-06-300001648257hcm:OtherVenturesSegmentMember2026-01-012026-06-300001648257hcm:OtherCollaborationRoyaltiesRevenueMember2026-01-012026-06-300001648257hcm:OtherCollaborationLicensingRevenueMember2026-01-012026-06-300001648257hcm:OncologyOrImmunologySegmentMember2026-01-012026-06-300001648257hcm:MarketedProductsMember2026-01-012026-06-300001648257hcm:LicenseAndCollaborationsManufacturingSupplyMember2026-01-012026-06-300001648257hcm:GoodsDistributionMember2026-01-012026-06-300001648257hcm:CustomerMember2026-01-012026-06-300001648257hcm:CustomerBMember2026-01-012026-06-300001648257hcm:CommercializationServicesMember2026-01-012026-06-300001648257hcm:CollaborationResearchAndDevelopmentMember2026-01-012026-06-300001648257country:CN2026-01-012026-06-300001648257us-gaap:RelatedPartyMemberhcm:OtherVenturesSegmentMember2025-01-012025-06-300001648257us-gaap:NonrelatedPartyMemberhcm:OtherVenturesSegmentMember2025-01-012025-06-300001648257us-gaap:NonrelatedPartyMemberhcm:OncologyOrImmunologySegmentMember2025-01-012025-06-300001648257hcm:RelatedPartyTransactionSalesOfGoodsMemberus-gaap:EquityMethodInvesteeMember2025-01-012025-06-300001648257hcm:OtherCollaborationRoyaltiesRevenueMemberus-gaap:NonrelatedPartyMember2025-01-012025-06-300001648257hcm:OtherCollaborationRoyaltiesRevenueMemberhcm:OncologyOrImmunologySegmentMember2025-01-012025-06-300001648257hcm:OtherCollaborationLicensingRevenueMemberus-gaap:NonrelatedPartyMember2025-01-012025-06-300001648257hcm:OtherCollaborationLicensingRevenueMemberhcm:OncologyOrImmunologySegmentMember2025-01-012025-06-300001648257hcm:MarketedProductsMemberhcm:OncologyOrImmunologySegmentMember2025-01-012025-06-300001648257hcm:LicenseAndCollaborationsManufacturingSupplyMemberhcm:OncologyOrImmunologySegmentMember2025-01-012025-06-300001648257hcm:GoodsDistributionMemberhcm:OtherVenturesSegmentMember2025-01-012025-06-300001648257hcm:CommercializationServicesMemberhcm:OncologyOrImmunologySegmentMember2025-01-012025-06-300001648257hcm:CollaborationResearchAndDevelopmentMemberus-gaap:NonrelatedPartyMember2025-01-012025-06-300001648257hcm:CollaborationResearchAndDevelopmentMemberhcm:OncologyOrImmunologySegmentMember2025-01-012025-06-300001648257us-gaap:RelatedPartyMember2025-01-012025-06-300001648257us-gaap:NonrelatedPartyMember2025-01-012025-06-300001648257hcm:UnitedStatesAndOthersMember2025-01-012025-06-300001648257hcm:OtherVenturesSegmentMember2025-01-012025-06-300001648257hcm:OtherCollaborationRoyaltiesRevenueMember2025-01-012025-06-300001648257hcm:OtherCollaborationLicensingRevenueMember2025-01-012025-06-300001648257hcm:OncologyOrImmunologySegmentMember2025-01-012025-06-300001648257hcm:MarketedProductsMember2025-01-012025-06-300001648257hcm:LicenseAndCollaborationsManufacturingSupplyMember2025-01-012025-06-300001648257hcm:GoodsDistributionMember2025-01-012025-06-300001648257hcm:CustomerMember2025-01-012025-06-300001648257hcm:CustomerBMember2025-01-012025-06-300001648257hcm:CommercializationServicesMember2025-01-012025-06-300001648257hcm:CollaborationResearchAndDevelopmentMember2025-01-012025-06-300001648257country:CN2025-01-012025-06-300001648257hcm:CollaborativeArrangementsMember2026-01-012026-06-300001648257hcm:CollaborativeArrangementsMember2025-01-012025-06-300001648257hcm:FixedAssetLoanFacilityMember2026-01-012026-06-300001648257hcm:FixedAssetLoanFacilityMember2025-01-012025-12-310001648257us-gaap:EquityMethodInvesteeMember2026-01-012026-06-300001648257us-gaap:EquityMethodInvesteeMember2025-01-012025-06-300001648257us-gaap:RetainedEarningsMember2026-01-012026-06-300001648257hcm:ShanghaiHutchisonPharmaceuticalsLimitedMember2025-04-252025-04-250001648257us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-01-012026-06-300001648257hcm:RelatedPartyTransactionManagementServiceMembersrt:AffiliatedEntityMember2026-01-012026-06-300001648257hcm:RelatedPartyTransactionManagementServiceMembersrt:AffiliatedEntityMember2025-01-012025-06-300001648257us-gaap:CapitalAdditionsMember2026-01-012026-06-300001648257hcm:ShortTermWorkingCapitalLoanFacilityMember2025-10-310001648257hcm:FixedAssetLoanFacilityMember2021-10-310001648257hcm:ShortTermWorkingCapitalLoanFacilityMember2026-06-300001648257hcm:FixedAssetLoanFacilityMember2026-06-300001648257hcm:ShortTermWorkingCapitalLoanFacilityMember2025-12-310001648257hcm:FixedAssetLoanFacilityMember2025-12-310001648257hcm:ImagenebioIncMember2026-06-300001648257hcm:ShanghaiHutchisonPharmaceuticalsLimitedMember2025-12-310001648257hcm:ImagenebioIncMember2025-12-310001648257hcm:HCMLShareOptionSchemeMember2026-06-300001648257country:HK2026-01-012026-06-300001648257us-gaap:OperatingSegmentsMemberhcm:OncologyOrImmunologySegmentMemberhcm:ResearchAndDevelopmentSubsegmentMember2026-01-012026-06-300001648257hcm:CorporateAndReconcilingItemsMember2026-01-012026-06-300001648257us-gaap:OperatingSegmentsMemberhcm:OncologyOrImmunologySegmentMemberhcm:ResearchAndDevelopmentSubsegmentMember2025-01-012025-06-300001648257hcm:LongTermIncentivePlanMember2026-06-300001648257hcm:LongTermIncentivePlanMember2025-12-310001648257hcm:FixedAssetLoanFacilityMember2021-10-012021-10-310001648257hcm:ShortTermWorkingCapitalLoanFacilityMemberhcm:OneYearChinaLoanPrimeRateMember2025-10-012025-10-310001648257hcm:FixedAssetLoanFacilityMemberhcm:FiveYearChinaLoanPrimeRateMember2021-10-012021-10-310001648257us-gaap:ForeignTaxJurisdictionOtherMember2026-01-012026-06-300001648257us-gaap:ForeignTaxJurisdictionOtherMember2025-01-012025-06-300001648257country:CN2025-01-012025-06-300001648257us-gaap:OperatingSegmentsMemberhcm:OncologyOrImmunologySegmentMemberhcm:MarketedProductsSubsegmentMember2026-01-012026-06-300001648257us-gaap:ProductMemberus-gaap:RelatedPartyMember2026-01-012026-06-300001648257us-gaap:ProductMemberus-gaap:NonrelatedPartyMember2026-01-012026-06-300001648257us-gaap:OperatingSegmentsMemberhcm:OtherVenturesSegmentMember2026-01-012026-06-300001648257us-gaap:OperatingSegmentsMemberhcm:OncologyOrImmunologySegmentMember2026-01-012026-06-300001648257hcm:CommercializationServicesMemberus-gaap:NonrelatedPartyMember2026-01-012026-06-300001648257us-gaap:OperatingSegmentsMemberhcm:OncologyOrImmunologySegmentMemberhcm:MarketedProductsSubsegmentMember2025-01-012025-06-300001648257us-gaap:ProductMemberus-gaap:RelatedPartyMember2025-01-012025-06-300001648257us-gaap:ProductMemberus-gaap:NonrelatedPartyMember2025-01-012025-06-300001648257us-gaap:OperatingSegmentsMemberhcm:OtherVenturesSegmentMember2025-01-012025-06-300001648257us-gaap:OperatingSegmentsMemberhcm:OncologyOrImmunologySegmentMember2025-01-012025-06-300001648257hcm:CommercializationServicesMemberus-gaap:NonrelatedPartyMember2025-01-012025-06-300001648257hcm:OtherVenturesSegmentMember2026-06-300001648257hcm:OncologyOrImmunologySegmentMember2026-06-300001648257hcm:OtherVenturesSegmentMember2025-12-310001648257hcm:OncologyOrImmunologySegmentMember2025-12-310001648257us-gaap:CommonStockMember2026-06-300001648257us-gaap:CommonStockMember2025-12-310001648257us-gaap:CommonStockMember2025-06-300001648257us-gaap:CommonStockMember2024-12-310001648257srt:OtherCurrencyMember2026-06-300001648257currency:USD2026-06-300001648257currency:HKD2026-06-300001648257currency:GBP2026-06-300001648257currency:CNY2026-06-300001648257srt:OtherCurrencyMember2025-12-310001648257currency:USD2025-12-310001648257currency:HKD2025-12-310001648257currency:GBP2025-12-310001648257currency:CNY2025-12-310001648257us-gaap:OperatingSegmentsMemberhcm:OncologyOrImmunologySegmentMemberhcm:MarketedProductsSubsegmentMember2026-06-300001648257us-gaap:OperatingSegmentsMemberhcm:OtherVenturesSegmentMember2026-06-300001648257hcm:UnitedStatesAndOthersMember2026-06-300001648257hcm:CorporateAndReconcilingItemsMember2026-06-300001648257us-gaap:OperatingSegmentsMemberhcm:OncologyOrImmunologySegmentMemberhcm:MarketedProductsSubsegmentMember2025-12-310001648257us-gaap:OperatingSegmentsMemberhcm:OtherVenturesSegmentMember2025-12-310001648257hcm:UnitedStatesAndOthersMember2025-12-310001648257hcm:CorporateAndReconcilingItemsMember2025-12-3100016482572025-06-3000016482572024-12-310001648257us-gaap:SellingGeneralAndAdministrativeExpensesMemberhcm:LongTermIncentivePlanMember2026-01-012026-06-300001648257us-gaap:SellingGeneralAndAdministrativeExpensesMemberhcm:HCMLShareOptionSchemeMember2026-01-012026-06-300001648257us-gaap:ResearchAndDevelopmentExpenseMemberhcm:LongTermIncentivePlanMember2026-01-012026-06-300001648257us-gaap:ResearchAndDevelopmentExpenseMemberhcm:HCMLShareOptionSchemeMember2026-01-012026-06-300001648257us-gaap:CostOfSalesMemberhcm:LongTermIncentivePlanMember2026-01-012026-06-300001648257us-gaap:CostOfSalesMemberhcm:HCMLShareOptionSchemeMember2026-01-012026-06-300001648257hcm:LongTermIncentivePlanMemberus-gaap:LiabilityMember2026-01-012026-06-300001648257hcm:LongTermIncentivePlanMemberus-gaap:AdditionalPaidInCapitalMember2026-01-012026-06-300001648257us-gaap:SellingGeneralAndAdministrativeExpensesMemberhcm:LongTermIncentivePlanMember2025-01-012025-06-300001648257us-gaap:SellingGeneralAndAdministrativeExpensesMemberhcm:HCMLShareOptionSchemeMember2025-01-012025-06-300001648257us-gaap:ResearchAndDevelopmentExpenseMemberhcm:LongTermIncentivePlanMember2025-01-012025-06-300001648257us-gaap:ResearchAndDevelopmentExpenseMemberhcm:HCMLShareOptionSchemeMember2025-01-012025-06-300001648257us-gaap:CostOfSalesMemberhcm:LongTermIncentivePlanMember2025-01-012025-06-300001648257us-gaap:CostOfSalesMemberhcm:HCMLShareOptionSchemeMember2025-01-012025-06-300001648257hcm:LongTermIncentivePlanMemberus-gaap:LiabilityMember2025-01-012025-06-300001648257hcm:LongTermIncentivePlanMemberus-gaap:AdditionalPaidInCapitalMember2025-01-012025-06-300001648257hcm:HCMLShareOptionSchemeMember2025-01-012025-06-300001648257us-gaap:NoncontrollingInterestMember2026-01-012026-06-300001648257us-gaap:NoncontrollingInterestMember2025-01-012025-06-300001648257hcm:NotLaterThanThreeMonthsMemberus-gaap:NonrelatedPartyMember2026-06-300001648257hcm:LaterThanOneYearMemberus-gaap:NonrelatedPartyMember2026-06-300001648257hcm:BetweenThreeMonthsToSixMonthsMemberus-gaap:NonrelatedPartyMember2026-06-300001648257hcm:BetweenSixMonthsToOneYearMemberus-gaap:NonrelatedPartyMember2026-06-300001648257hcm:NotLaterThanThreeMonthsMemberus-gaap:NonrelatedPartyMember2025-12-310001648257hcm:LaterThanOneYearMemberus-gaap:NonrelatedPartyMember2025-12-310001648257hcm:BetweenThreeMonthsToSixMonthsMemberus-gaap:NonrelatedPartyMember2025-12-310001648257hcm:BetweenSixMonthsToOneYearMemberus-gaap:NonrelatedPartyMember2025-12-310001648257hcm:SeroquelMember2026-06-300001648257hcm:NotLaterThanThreeMonthsMember2026-06-300001648257hcm:LaterThanOneYearMember2026-06-300001648257hcm:BetweenThreeMonthsToSixMonthsMember2026-06-300001648257hcm:BetweenSixMonthsToOneYearMember2026-06-300001648257hcm:NotLaterThanThreeMonthsMember2025-12-310001648257hcm:LaterThanOneYearMember2025-12-310001648257hcm:BetweenThreeMonthsToSixMonthsMember2025-12-310001648257hcm:BetweenSixMonthsToOneYearMember2025-12-310001648257us-gaap:RetainedEarningsMember2025-01-012025-06-300001648257srt:MinimumMember2026-01-012026-06-300001648257srt:MaximumMember2026-01-012026-06-300001648257srt:MinimumMember2025-01-012025-12-310001648257srt:MaximumMember2025-01-012025-12-310001648257us-gaap:ParentMember2026-01-012026-06-300001648257us-gaap:AdditionalPaidInCapitalMember2026-01-012026-06-300001648257hcm:LongTermIncentivePlanMember2026-01-012026-06-300001648257hcm:LongTermIncentivePlanMember2025-01-012025-06-300001648257hcm:AwardsVestingInFourYearsMemberhcm:HCMLShareOptionSchemeMember2026-06-300001648257hcm:HCMLShareOptionSchemeMember2026-01-012026-06-300001648257hcm:OrdinarySharesOrAmericanDepositaryShareMemberhcm:LongTermIncentivePlanMember2026-01-012026-06-300001648257hcm:OrdinarySharesOrAmericanDepositaryShareMemberhcm:LongTermIncentivePlanMember2025-01-012025-06-300001648257hcm:ShanghaiHutchisonPharmaceuticalsLimitedMember2026-01-012026-06-300001648257hcm:ShanghaiHutchisonPharmaceuticalsLimitedMember2025-01-012025-12-3100016482572025-01-012025-12-310001648257srt:AffiliatedEntityMember2026-01-012026-06-300001648257us-gaap:RelatedPartyMember2026-06-300001648257us-gaap:EquityMethodInvesteeMember2026-06-300001648257srt:AffiliatedEntityMember2026-06-300001648257hcm:NonControllingShareholdersOfSubsidiariesMember2026-06-300001648257us-gaap:RelatedPartyMember2025-12-310001648257us-gaap:EquityMethodInvesteeMember2025-12-310001648257srt:AffiliatedEntityMember2025-12-310001648257hcm:NonControllingShareholdersOfSubsidiariesMember2025-12-310001648257us-gaap:NonrelatedPartyMember2026-06-300001648257us-gaap:NonrelatedPartyMember2025-12-310001648257hcm:ShanghaiHutchisonPharmaceuticalsLimitedMember2026-06-300001648257us-gaap:SubsequentEventMember2026-07-0100016482572022-06-2700016482572021-10-212021-10-210001648257us-gaap:OperatingSegmentsMemberhcm:OncologyOrImmunologySegmentMemberhcm:ResearchAndDevelopmentSubsegmentMember2026-06-300001648257us-gaap:OperatingSegmentsMemberhcm:OncologyOrImmunologySegmentMember2026-06-300001648257country:CN2026-06-300001648257us-gaap:OperatingSegmentsMemberhcm:OncologyOrImmunologySegmentMemberhcm:ResearchAndDevelopmentSubsegmentMember2025-12-310001648257us-gaap:OperatingSegmentsMemberhcm:OncologyOrImmunologySegmentMember2025-12-310001648257country:CN2025-12-310001648257hcm:CorporateAndReconcilingItemsMember2025-01-012025-06-300001648257hcm:TwoChinaBasedPrivateEquityFundsMemberhcm:ShanghaiHutchisonPharmaceuticalsLimitedMember2025-04-250001648257hcm:ParentCompanyOfCoVenturerMemberhcm:ShanghaiHutchisonPharmaceuticalsLimitedMember2025-04-250001648257hcm:ShanghaiHutchisonPharmaceuticalsLimitedMember2025-04-250001648257country:CN2026-01-012026-06-300001648257hcm:DueFromRelatedPartiesMemberus-gaap:EquityMethodInvesteeMember2026-06-300001648257hcm:DueFromRelatedPartiesMemberus-gaap:EquityMethodInvesteeMember2025-12-310001648257us-gaap:ParentMember2025-01-012025-06-300001648257us-gaap:AdditionalPaidInCapitalMember2025-01-012025-06-300001648257us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-06-300001648257hcm:NonControllingShareholdersOfSubsidiariesMember2026-01-012026-06-300001648257hcm:NonControllingShareholdersOfSubsidiariesMember2025-01-012025-06-300001648257hcm:TwoChinaBasedPrivateEquityFundsMemberhcm:ShanghaiHutchisonPharmaceuticalsLimitedMember2025-04-252025-04-250001648257hcm:ShanghaiHutchisonPharmaceuticalsLimitedMember2025-01-012025-06-3000016482572025-01-012025-06-300001648257hcm:ShanghaiHutchisonPharmaceuticalsLimitedMember2025-06-3000016482572026-06-3000016482572025-12-31iso4217:USDiso4217:CNYxbrli:purehcm:itemhcm:directoriso4217:USDxbrli:sharesxbrli:shareshcm:claim

​

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

For the Month of July 2026

Commission File Number: 001-37710

HUTCHMED (CHINA) LIMITED

(Translation of registrant’s name into English)

48th Floor, Cheung Kong Center, 2 Queen’s Road Central, Hong Kong

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ⌧ Form 40-F ☐

​

​

​

​

HUTCHMED (CHINA) LIMITED

Form 6-K

EXHIBIT INDEX

​

Exhibit No.

  ​ ​ ​

Description

Exhibit 99.1

​

Announcement relating to unaudited financial results as of and for the six months ended June 30, 2026

Exhibit 99.2

​

HUTCHMED (China) Limited supplemental disclosures

​

​

​

​

​

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

​

HUTCHMED (CHINA) LIMITED

​

​

​

​

​

​

​

By:

/s/ JOHNNY CHENG

​

​

Name:

Johnny Cheng

​

​

Title:

Chief Financial Officer

​

Date: July 30, 2026

​

​

ATTACHMENTS / EXHIBITS

ATTACHMENTS / EXHIBITS

EX-99.1

EX-99.2

EX-101.SCH

EX-101.CAL

EX-101.DEF

EX-101.LAB

EX-101.PRE

IDEA: R1.htm

IDEA: R2.htm

IDEA: R3.htm

IDEA: R4.htm

IDEA: R5.htm

IDEA: R6.htm

IDEA: R7.htm

IDEA: R8.htm

IDEA: R9.htm

IDEA: R10.htm

IDEA: R11.htm

IDEA: R12.htm

IDEA: R13.htm

IDEA: R14.htm

IDEA: R15.htm

IDEA: R16.htm

IDEA: R17.htm

IDEA: R18.htm

IDEA: R19.htm

IDEA: R20.htm

IDEA: R21.htm

IDEA: R22.htm

IDEA: R23.htm

IDEA: R24.htm

IDEA: R25.htm

IDEA: R26.htm

IDEA: R27.htm

IDEA: R28.htm

IDEA: R29.htm

IDEA: R30.htm

IDEA: R31.htm

IDEA: R32.htm

IDEA: R33.htm

IDEA: R34.htm

IDEA: R35.htm

IDEA: R36.htm

IDEA: R37.htm

IDEA: R38.htm

IDEA: R39.htm

IDEA: R40.htm

IDEA: R41.htm

IDEA: R42.htm

IDEA: R43.htm

IDEA: R44.htm

IDEA: R45.htm

IDEA: R46.htm

IDEA: R47.htm

IDEA: R48.htm

IDEA: R49.htm

IDEA: R50.htm

IDEA: R51.htm

IDEA: R52.htm

IDEA: R53.htm

IDEA: R54.htm

IDEA: R55.htm

IDEA: R56.htm

IDEA: R57.htm

IDEA: R58.htm

IDEA: R59.htm

IDEA: R60.htm

IDEA: R61.htm

IDEA: R62.htm

IDEA: R63.htm

IDEA: R64.htm

IDEA: R65.htm

IDEA: R66.htm

IDEA: R67.htm

IDEA: R68.htm

IDEA: R69.htm

IDEA: R70.htm

IDEA: R71.htm

IDEA: R72.htm

IDEA: R73.htm

IDEA: R74.htm

IDEA: R75.htm

IDEA: R76.htm

IDEA: R77.htm

IDEA: R78.htm

IDEA: R79.htm

IDEA: R80.htm

IDEA: R81.htm

IDEA: R82.htm

IDEA: R83.htm

IDEA: R84.htm

IDEA: R85.htm

IDEA: R86.htm

IDEA: R87.htm

IDEA: R88.htm

IDEA: R89.htm

IDEA: R90.htm

IDEA: R91.htm

IDEA: FilingSummary.xml

IDEA: MetaLinks.json

IDEA: hcm-20260730x6k_htm.xml